Comparative Evaluation of Glutamate-Sensitive Radiopharmaceuticals: Technetium-99m–Glutamic Acid and Technetium-99m–Diethylenetriaminepentaacetic Acid–bis(Glutamate) Conjugate for Tumor Imaging
- 1 December 2010
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (6) , 645-655
Abstract
Single-photon emission computed tomography has become a significant imaging modality with huge potential to visualize and provide information of anatomic dysfunctions that are predictive of future diseases. This imaging tool is complimented by radiopharmaceuticals/radiosubstrates that help in imaging specific physiological aspects of the human body. The present study was undertaken to explore the utility of technetium-99m ( 99m Tc)–labeled glutamate conjugates for tumor scintigraphy. As part of our efforts to further utilize the application of chelating agents, glutamic acid was conjugated with a multidentate ligand, diethylenetriaminepentaacetic acid (DTPA). The DTPA–glutamate conjugate [DTPA-bis(Glu)] was well characterized by IR, NMR, and mass spectroscopy. The biological activity of glutamic acid was compared with its DTPA conjugate by radiocomplexation with 99m Tc (labeling efficiency ≥98%). In vivo studies of both the radiolabeled complexes 99m Tc-Glu and 99m Tc-DTPA-bis(Glu) were then carried out, followed by gamma scintigraphy in New Zealand albino rabbits. Improved serum stability of 99m Tc-labeled DTPA conjugate indicated that 99m Tc remained bound to the conjugate up to 24 hours. Blood clearance showed a relatively slow washout of the DTPA conjugate when compared with the labeled glutamate. Biodistribution characteristics of the conjugate in Balb/c mice revealed that DTPA conjugation of glutamic acid favors less accumulation in the liver and bone and rapid renal clearance. Tumor scintigraphy in mice showed increasing tumor accumulation, stable up to 4 hours. These preliminary studies show that 99m Tc-DTPA-bis(Glu) can be a useful radiopharmaceutical for diagnostic applications in single-photon emission computed tomography imaging.Keywords
This publication has 23 references indexed in Scilit:
- 11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral GliomasMolecular Imaging and Biology, 2007
- Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with gliomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Peptide radiopharmaceuticals for diagnosis and therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- RP463: A Stabilized Technetium-99m Complex of a Hydrazino Nicotinamide Derivatized Chemotactic Peptide for Infection ImagingBioconjugate Chemistry, 1999
- Noninvasive Assessment of Tumor Hypoxia with 99mTc Labeled MetronidazolePharmaceutical Research, 1999
- Review: How Amino Acids Get Into Cells: Mechanisms, Models, Menus, and MediatorsJournal of Parenteral and Enteral Nutrition, 1992
- l-Glutamine transport in native vesicles isolated from Ehrlich ascites tumor cell membranesJournal of Bioenergetics and Biomembranes, 1991
- Aspects of amino acid and protein metabolism in cancer-bearing statesCancer, 1985
- Amino Acid Transport in Tumor Cells1965